Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001986890 | SCV002280056 | uncertain significance | Wiskott-Aldrich syndrome 2 | 2021-04-21 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with WIPF1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs770870596, ExAC no frequency). This sequence change replaces proline with leucine at codon 378 of the WIPF1 protein (p.Pro378Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. |
Center for Genomics, |
RCV001986890 | SCV003920626 | uncertain significance | Wiskott-Aldrich syndrome 2 | 2022-04-29 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest MAF: 0.03% [1/34380] https://gnomad.broadinstitute.org/variant/2-175432798-G-A?dataset=gnomad_r2_1) and in ClinVar (Variation ID:1493985). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |